Alpha Lipoic Acid (ALA) for Post-Meal Glucose Control
ALA has better evidence for diabetic neuropathy than for glucose control itself.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 600mg/day, taken fasted
- Expected timeframe
- 8-12 weeks
Protocol
- studied dose
- 600-1200 mg/day taken fasted in meta-analysed trials
- evidence note
- Verdict is insufficient - the studied dose did not meaningfully change post-meal glucose
- what happened
- Only small fasting glucose and HOMA-IR improvements appeared; post-prandial excursions were not reliably reduced, and the signal is far weaker than the neuropathy data that underpins ALA's clinical use
- better first choices
- Apple cider vinegar or 3 g American ginseng before a starchy meal, a pre-meal walk, or protein-first meal sequencing
- if you still trial it
- 600 mg fasted each morning for 12 weeks with continuous glucose monitoring, so you can see whether your own post-meal curve changes
Evidence
What the studies say
No studies are yet linked to both Alpha Lipoic Acid (ALA) and Post-Meal Glucose Control.
Safety
Caveats
May potentiate glucose-lowering medication. Rare thiamine depletion with long-term use.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.